DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactEarnings

Invicta Diagnostic Limited — Outcome of Board Meeting

NSE 25 Aug·25 Aug 2026, 12:40 pm

Invicta Diagnostic

Invicta Diagnostic Limited has informed stock exchanges that its board met on August 25, 2026. The company has not yet disclosed the specific agenda items or outcomes of this meeting. This is a standard corporate disclosure required for any significant board deliberation.

For investors, the lack of immediate details means there is currently no new information to act upon. While board meetings often cover strategic plans or financial approvals, the market will need to wait for the official announcement to understand the full impact. Investors should monitor the company's filings for any updates on this matter.